Voyager Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Voyager Therapeutics

26/02/2024 22:24

* Voyager Therapeutics Inc  VYGR.OQ   VYGR.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
28 for the period ending December 31 2023
    * The Lexington Massachusetts-based  company is expected to
report
a 1,431.3% decrease in revenue to $20.635 million from $-1.55
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data. (Revenue basis is on Total Revenue
basis)
    * ​LSEG's mean analyst estimate for Voyager Therapeutics Inc
is
for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $16.00​, above​ its last closing price
of $8.18. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.57       -0.58      -0.59     Missed  -1.5
 Jun. 30 2023  -0.57       -0.57      -0.51     Beat    10.3
 Mar. 31 2023  1.00        0.77       2.94      Beat    281​
 Dec. 31 2022  -0.54       -0.55      -0.61     Missed  -11.5
 ​​Sep.        -0.31       -0.32      0.45      Beat    241.9
 30 2022                                                
 Jun. 30 2022  -0.48       -0.32      -0.50     Missed  -57.5​
 Mar. 31 2022  -0.25       -0.34      -0.56     Missed  -62.7
 Dec. 31 2021  -0.71       -0.32      0.15      Beat    147.4
 This summary was machine generated February 26 at 22:24 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)